Paul J Sekhri has an estimated net worth of $10.3 Million. This is based on reported shares across multiple companies, which include VEEVA SYSTEMS INC, Enumeral Biomedical Holdings, Inc., ARYx Therapeutics, Inc., Biodel Inc, ALPINE IMMUNE SCIENCES, INC., Longboard Pharmaceuticals, Inc., BiomX Inc., vTv Therapeutics Inc., Axcella Health Inc., and ARIAD PHARMACEUTICALS INC.

2024 was Paul J Sekhri's most active year for acquiring shares with 10 total transactions. Paul J Sekhri's most active month to acquire stocks was the month of May. 2018 was Paul J Sekhri's most active year for disposing of shares, totalling 15 transactions. Paul J Sekhri's most active month to dispose stocks was the month of November. 2026 saw Paul J Sekhri paying a total of $5,168,800.00 for 140,253 shares, this is the most they've acquired in one year. In 2022 Paul J Sekhri cashed out on 12,706 shares for a total of $2,354,254.10, their largest year based on trade value.